A grant awarded to UC San Diego will allow researchers to continue working with law enforcement and health professionals to develop educational programs and interventions that reduce traffic-related injuries and deaths.
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic. Click here to view original post… […]
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
[…]
Smokers were not early adopters of high nicotine e-cigarettes as cessation aids despite the rapid growth of sales of these products in 2017, report Herbert Wertheim School of Public Health and Human Longevity Science at Univers… […]
Copyright © 2022 Biotech Networks, LLC
